NSRX · Nasus Pharma Ltd.

Summary

Nasus Pharma Ltd. filed Exhibit 99.1 containing its Amended and Restated Articles of Association under the Israeli Companies Law, 1999. The amendments define key terms, confirm the company's status as a public limited liability company, authorize 50,000,000 no par-value Ordinary Shares, and outline governance provisions for share capital changes, issuance, and shareholder rights.

Key takeaways

• Company is Nasus Pharma Ltd., a public company under Israeli Companies Law.
• Authorized share capital: 50,000,000 Ordinary Shares, no par-value, ranking pari passu.
• Board of Directors controls issuance of unissued shares and convertible securities.
• Shareholders may increase authorized capital by resolution.
• Company may repurchase shares subject to Companies Law.
• Articles permit donations for purposes deemed appropriate by Board.